← Open Payments lookup

MARK CANNON: Open Payments

NPI 1720169295 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,377 in 253 payments from 14 companies in 2025. Trend: 2023 $2,451 · 2024 $3,270 · 2025 $3,377

Food & beverage: $3,377
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.45$529
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$410
ABBVIE INC.41$397
Alkermes, Inc.20$363
Otsuka America Pharmaceutical, Inc.21$327
Neurocrine BioSciences, Inc.15$323
Vanda Pharmaceuticals Inc.34$320
Axsome Therapeutics, Inc.16$211
Janssen Pharmaceuticals, Inc10$200
Teva Pharmaceuticals USA, Inc.17$173

Products named: COBENFY, CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, HETLIOZ, REXULTI, Auvelity.

Industry payments across MO — which companies pay providers there.